In Her2BC, the bidirectional crosstalk between HER2 and ER in BC could promote cell proliferation and survival through the phosphorylation of ERα and its co-regulators despite the absence of ER, which stimulates ER signaling pathways, such as downstream RAS, PI3K/AKT, and MAPK [174]. Here, ERBB2 is linked to breast cancer.